As the first drug approved for this indication since 2014, semaglutide has been deemed practice changing, since it showed a reduction in body weight of approximately 15-18% across four phase 3 trials [23]
In addition to the reduced glutathione (GSH)/GPX4 axis, ferroptosis is inhibited by the ferroptosis suppressor protein 1 (FSP1)/coenzyme Q10 (CoQ10), GTP cyclohydrolase 1 (GCH1)/tetrahydrobiopterin (BH4), and dihydroorotate dehydrogenase (DHODH)/CoQH2 pathways [162]
Table 1 summarizes the characteristics and main findings regarding probiotic effects on RA in preclinical studies
Characterization of the parasite TGR revealed enzymatic properties that differed from those of mammalian TGR, TrxR, and GR
Common reports from clinical use include mild injection-site irritation, a brief stinging sensation (attributable to the copper complex in GHK-Cu), and occasional temporary fatigue in the first week